Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 270 entries
Sorted by: Best Match Show Resources per page
Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Serruys PW, Vranckx P, Slagboom T, Regar E, Meliga E, de Winter RJ, Heyndrickx G, Schuler G, van Remortel EA, Dubé GP, Symons J.
PMID: 19608488
EuroIntervention. 2008 Mar;3(5):600-9. doi: 10.4244/eijv3i5a108.

AIMS: Haemoglobin based oxygen carriers (HBOCs) are considered in the treatment of patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI). In light of their potential vasopressor and colloidal properties, their effect on coronary physiology, safety and...

Cite
Serruys PW, Vranckx P, Slagboom T, et al. Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention. 2008;3(5):600-9doi: 10.4244/eijv3i5a108.
Serruys, P. W., Vranckx, P., Slagboom, T., Regar, E., Meliga, E., de Winter, R. J., Heyndrickx, G., Schuler, G., van Remortel, E. A., Dubé, G. P., & Symons, J. (2008). Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 3(5), 600-9. https://doi.org/10.4244/eijv3i5a108
Serruys, Patrick W, et al. "Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 3,5 (2008): 600-9. doi: https://doi.org/10.4244/eijv3i5a108
Serruys PW, Vranckx P, Slagboom T, Regar E, Meliga E, de Winter RJ, Heyndrickx G, Schuler G, van Remortel EA, Dubé GP, Symons J. Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention. 2008 Mar;3(5):600-9. doi: 10.4244/eijv3i5a108. PMID: 19608488.
Copy Download .nbib Format: NLM
Myocardial infarction in a patient with sickle cell trait. Treatment dilemmas and imaging findings at follow-up.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

van Mieghem C, Ramcharitar S, Barlis P, Oosterhuis W, Kik C, de Feyter P, Serruys PW.
PMID: 19608492
EuroIntervention. 2008 Mar;3(5):627-34. doi: 10.4244/eijv3i5a112.

BACKGROUND: A 43-year-old woman with a 2-hour history of chest pain presented with an anterior infarction and was referred for primary percutaneous coronary intervention.INVESTIGATIONS: Physical examination, electrocardiography, laboratory tests, coronary angiography, abdominal angiography, cardiac CT, histology, immunohistochemistry, intravascular ultrasound.DIAGNOSIS:...

Cite
van Mieghem C, Ramcharitar S, Barlis P, et al. Myocardial infarction in a patient with sickle cell trait. Treatment dilemmas and imaging findings at follow-up. EuroIntervention. 2008;3(5):627-34doi: 10.4244/eijv3i5a112.
van Mieghem, C., Ramcharitar, S., Barlis, P., Oosterhuis, W., Kik, C., de Feyter, P., & Serruys, P. W. (2008). Myocardial infarction in a patient with sickle cell trait. Treatment dilemmas and imaging findings at follow-up. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 3(5), 627-34. https://doi.org/10.4244/eijv3i5a112
van Mieghem, Carlos, et al. "Myocardial infarction in a patient with sickle cell trait. Treatment dilemmas and imaging findings at follow-up." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 3,5 (2008): 627-34. doi: https://doi.org/10.4244/eijv3i5a112
van Mieghem C, Ramcharitar S, Barlis P, Oosterhuis W, Kik C, de Feyter P, Serruys PW. Myocardial infarction in a patient with sickle cell trait. Treatment dilemmas and imaging findings at follow-up. EuroIntervention. 2008 Mar;3(5):627-34. doi: 10.4244/eijv3i5a112. PMID: 19608492.
Copy Download .nbib Format: NLM
Feasibility of planning coronary artery bypass grafting based only on coronary computed tomography angiography and CT-derived fractional flow reserve: a pilot survey of the surgeons involved in the randomized SYNTAX III Revolution trial.

Interactive cardiovascular and thoracic surgery

Sonck J, Miyazaki Y, Collet C, Onuma Y, Asano T, Takahashi K, Kogame N, Katagiri Y, Modolo R, Serruys PW, Bartorelli AL, Andreini D, Doenst T, Maureira JP, Plass A, La Meir M, Pompillio G.
PMID: 30887024
Interact Cardiovasc Thorac Surg. 2019 Mar 18; doi: 10.1093/icvts/ivz046. Epub 2019 Mar 18.

OBJECTIVES: Invasive coronary angiography has been the preferred diagnostic method to guide the decision-making process between coronary artery bypass grafting (CABG) and percutaneous coronary intervention and plan a surgical revascularization procedure. Guidelines recommend a heart team approach and assessment...

Cite
Sonck J, Miyazaki Y, Collet C, et al. Feasibility of planning coronary artery bypass grafting based only on coronary computed tomography angiography and CT-derived fractional flow reserve: a pilot survey of the surgeons involved in the randomized SYNTAX III Revolution trial. Interact Cardiovasc Thorac Surg. 2019;doi: 10.1093/icvts/ivz046.
Sonck, J., Miyazaki, Y., Collet, C., Onuma, Y., Asano, T., Takahashi, K., Kogame, N., Katagiri, Y., Modolo, R., Serruys, P. W., Bartorelli, A. L., Andreini, D., Doenst, T., Maureira, J. P., Plass, A., La Meir, M., & Pompillio, G. (2019). Feasibility of planning coronary artery bypass grafting based only on coronary computed tomography angiography and CT-derived fractional flow reserve: a pilot survey of the surgeons involved in the randomized SYNTAX III Revolution trial. Interactive cardiovascular and thoracic surgery, . https://doi.org/10.1093/icvts/ivz046
Sonck, Jeroen, et al. "Feasibility of planning coronary artery bypass grafting based only on coronary computed tomography angiography and CT-derived fractional flow reserve: a pilot survey of the surgeons involved in the randomized SYNTAX III Revolution trial." Interactive cardiovascular and thoracic surgery vol. (2019). doi: https://doi.org/10.1093/icvts/ivz046
Sonck J, Miyazaki Y, Collet C, Onuma Y, Asano T, Takahashi K, Kogame N, Katagiri Y, Modolo R, Serruys PW, Bartorelli AL, Andreini D, Doenst T, Maureira JP, Plass A, La Meir M, Pompillio G. Feasibility of planning coronary artery bypass grafting based only on coronary computed tomography angiography and CT-derived fractional flow reserve: a pilot survey of the surgeons involved in the randomized SYNTAX III Revolution trial. Interact Cardiovasc Thorac Surg. 2019 Mar 18; doi: 10.1093/icvts/ivz046. Epub 2019 Mar 18. PMID: 30887024.
Copy Download .nbib Format: NLM
Cherry-Picking Historical Data to Legitimize Contemporary Practice: Should Diabetic Status Influence Decision-Making in Complex CAD?.

Journal of the American College of Cardiology

Serruys PW, Farooq V.
PMID: 28126157
J Am Coll Cardiol. 2017 Jan 31;69(4):404-408. doi: 10.1016/j.jacc.2016.11.028.

No abstract available.

Cite
Serruys PW, Farooq V. Cherry-Picking Historical Data to Legitimize Contemporary Practice: Should Diabetic Status Influence Decision-Making in Complex CAD?. J Am Coll Cardiol. 2017;69(4):404-408doi: 10.1016/j.jacc.2016.11.028.
Serruys, P. W., & Farooq, V. (2017). Cherry-Picking Historical Data to Legitimize Contemporary Practice: Should Diabetic Status Influence Decision-Making in Complex CAD?. Journal of the American College of Cardiology, 69(4), 404-408. https://doi.org/10.1016/j.jacc.2016.11.028
Serruys, Patrick W, and Farooq, Vasim. "Cherry-Picking Historical Data to Legitimize Contemporary Practice: Should Diabetic Status Influence Decision-Making in Complex CAD?." Journal of the American College of Cardiology vol. 69,4 (2017): 404-408. doi: https://doi.org/10.1016/j.jacc.2016.11.028
Serruys PW, Farooq V. Cherry-Picking Historical Data to Legitimize Contemporary Practice: Should Diabetic Status Influence Decision-Making in Complex CAD?. J Am Coll Cardiol. 2017 Jan 31;69(4):404-408. doi: 10.1016/j.jacc.2016.11.028. PMID: 28126157.
Copy Download .nbib Format: NLM
EuroIntervention at 100 issues.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Serruys PW.
PMID: 27320421
EuroIntervention. 2016 Jun 20;12(3):295. doi: 10.4244/EIJV12I3A46.

No abstract available.

Cite
Serruys PW. EuroIntervention at 100 issues. EuroIntervention. 2016;12(3):295doi: 10.4244/EIJV12I3A46.
Serruys, P. W. (2016). EuroIntervention at 100 issues. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 12(3), 295. https://doi.org/10.4244/EIJV12I3A46
Serruys, Patrick W. "EuroIntervention at 100 issues." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 12,3 (2016): 295. doi: https://doi.org/10.4244/EIJV12I3A46
Serruys PW. EuroIntervention at 100 issues. EuroIntervention. 2016 Jun 20;12(3):295. doi: 10.4244/EIJV12I3A46. PMID: 27320421.
Copy Download .nbib Format: NLM
The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Kawashima H, Zocca P, Buiten RA, Smits PC, Onuma Y, Wykrzykowska JJ, de Winter RJ, von Birgelen C, Serruys PW.
PMID: 32780336
Neth Heart J. 2020 Aug;28:78-87. doi: 10.1007/s12471-020-01442-w.

Dutch researchers were among the first to perform clinical studies in bare metal coronary stents, the use of which was initially limited by a high incidence of in-stent restenosis. This problem was greatly solved by the introduction of drug-eluting...

Cite
Kawashima H, Zocca P, Buiten RA, et al. The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective. Neth Heart J. 2020;28:78-87doi: 10.1007/s12471-020-01442-w.
Kawashima, H., Zocca, P., Buiten, R. A., Smits, P. C., Onuma, Y., Wykrzykowska, J. J., de Winter, R. J., von Birgelen, C., & Serruys, P. W. (2020). The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2878-87. https://doi.org/10.1007/s12471-020-01442-w
Kawashima, H, et al. "The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 28 (2020): 78-87. doi: https://doi.org/10.1007/s12471-020-01442-w
Kawashima H, Zocca P, Buiten RA, Smits PC, Onuma Y, Wykrzykowska JJ, de Winter RJ, von Birgelen C, Serruys PW. The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective. Neth Heart J. 2020 Aug;28:78-87. doi: 10.1007/s12471-020-01442-w. PMID: 32780336; PMCID: PMC7419418.
Copy Download .nbib Format: NLM
Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.

European heart journal

Gaudino M, Di Franco A, Alexander JH, Bakaeen F, Egorova N, Kurlansky P, Boening A, Chikwe J, Demetres M, Devereaux PJ, Diegeler A, Dimagli A, Flather M, Hameed I, Lamy A, Lawton JS, Reents W, Robinson NB, Audisio K, Rahouma M, Serruys PW, Hara H, Taggart DP, Girardi LN, Fremes SE, Benedetto U.
PMID: 34338767
Eur Heart J. 2021 Dec 28;43(1):18-28. doi: 10.1093/eurheartj/ehab504.

AIMS: Data suggest that women have worse outcomes than men after coronary artery bypass grafting (CABG), but results have been inconsistent across studies. Due to the large differences in baseline characteristics between sexes, suboptimal risk adjustment due to low-quality...

Cite
Gaudino M, Di Franco A, Alexander JH, et al. Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. Eur Heart J. 2021;43(1):18-28doi: 10.1093/eurheartj/ehab504.
Gaudino, M., Di Franco, A., Alexander, J. H., Bakaeen, F., Egorova, N., Kurlansky, P., Boening, A., Chikwe, J., Demetres, M., Devereaux, P. J., Diegeler, A., Dimagli, A., Flather, M., Hameed, I., Lamy, A., Lawton, J. S., Reents, W., Robinson, N. B., Audisio, K., Rahouma, M., Serruys, P. W., Hara, H., Taggart, D. P., Girardi, L. N., Fremes, S. E., & Benedetto, U. (2021). Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. European heart journal, 43(1), 18-28. https://doi.org/10.1093/eurheartj/ehab504
Gaudino, Mario, et al. "Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data." European heart journal vol. 43,1 (2021): 18-28. doi: https://doi.org/10.1093/eurheartj/ehab504
Gaudino M, Di Franco A, Alexander JH, Bakaeen F, Egorova N, Kurlansky P, Boening A, Chikwe J, Demetres M, Devereaux PJ, Diegeler A, Dimagli A, Flather M, Hameed I, Lamy A, Lawton JS, Reents W, Robinson NB, Audisio K, Rahouma M, Serruys PW, Hara H, Taggart DP, Girardi LN, Fremes SE, Benedetto U. Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. Eur Heart J. 2021 Dec 28;43(1):18-28. doi: 10.1093/eurheartj/ehab504. PMID: 34338767.
Copy Download .nbib Format: NLM
A comparison of risk prediction models for patients with acute coronary syndromes.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Hara H, O'Leary N, Ono M, Onuma Y, Serruys PW.
PMID: 34387548
EuroIntervention. 2021 Aug 17; doi: 10.4244/EIJ-D-21-00536. Epub 2021 Aug 17.

No abstract available.

Cite
Hara H, O'Leary N, Ono M, et al. A comparison of risk prediction models for patients with acute coronary syndromes. EuroIntervention. 2021;doi: 10.4244/EIJ-D-21-00536.
Hara, H., O'Leary, N., Ono, M., Onuma, Y., & Serruys, P. W. (2021). A comparison of risk prediction models for patients with acute coronary syndromes. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, . https://doi.org/10.4244/EIJ-D-21-00536
Hara, Hironori, et al. "A comparison of risk prediction models for patients with acute coronary syndromes." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. (2021). doi: https://doi.org/10.4244/EIJ-D-21-00536
Hara H, O'Leary N, Ono M, Onuma Y, Serruys PW. A comparison of risk prediction models for patients with acute coronary syndromes. EuroIntervention. 2021 Aug 17; doi: 10.4244/EIJ-D-21-00536. Epub 2021 Aug 17. PMID: 34387548.
Copy Download .nbib Format: NLM
The revolution project: replacing coronary artery angiography with coronary computed tomography with functional evaluation.

European heart journal supplements : journal of the European Society of Cardiology

Bartorelli AL, Andreini D, Mushtaq S, Serruys PW.
PMID: 33654462
Eur Heart J Suppl. 2020 Nov 18;22:L15-L18. doi: 10.1093/eurheartj/suaa126. eCollection 2020 Nov.

In the last two decades, several studies and widespread clinical use demonstrated that coronary computed tomography angiography (CCTA) is an appropriate method for the non-invasive assessment of patients with suspected stable coronary artery disease (CAD) and low-to-intermediate pretest likelihood...

Cite
Bartorelli AL, Andreini D, Mushtaq S, et al. The revolution project: replacing coronary artery angiography with coronary computed tomography with functional evaluation. Eur Heart J Suppl. 2020;22:L15-L18doi: 10.1093/eurheartj/suaa126.
Bartorelli, A. L., Andreini, D., Mushtaq, S., & Serruys, P. W. (2020). The revolution project: replacing coronary artery angiography with coronary computed tomography with functional evaluation. European heart journal supplements : journal of the European Society of Cardiology, 22L15-L18. https://doi.org/10.1093/eurheartj/suaa126
Bartorelli, Antonio L, et al. "The revolution project: replacing coronary artery angiography with coronary computed tomography with functional evaluation." European heart journal supplements : journal of the European Society of Cardiology vol. 22 (2020): L15-L18. doi: https://doi.org/10.1093/eurheartj/suaa126
Bartorelli AL, Andreini D, Mushtaq S, Serruys PW. The revolution project: replacing coronary artery angiography with coronary computed tomography with functional evaluation. Eur Heart J Suppl. 2020 Nov 18;22:L15-L18. doi: 10.1093/eurheartj/suaa126. eCollection 2020 Nov. PMID: 33654462; PMCID: PMC7904056.
Copy Download .nbib Format: NLM
Reply: Does Repeat Revascularization Introduce Bias for Reducing Mortality in the Antiplatelet Therapy Group?.

Journal of the American College of Cardiology

Kawashima H, Serruys PW, Wang R, Lunardi M, Onuma Y.
PMID: 34763784
J Am Coll Cardiol. 2021 Nov 16;78(20):e173-e174. doi: 10.1016/j.jacc.2021.09.012.

No abstract available.

Cite
Kawashima H, Serruys PW, Wang R, et al. Reply: Does Repeat Revascularization Introduce Bias for Reducing Mortality in the Antiplatelet Therapy Group?. J Am Coll Cardiol. 2021;78(20):e173-e174doi: 10.1016/j.jacc.2021.09.012.
Kawashima, H., Serruys, P. W., Wang, R., Lunardi, M., Onuma, Y. (2021). Reply: Does Repeat Revascularization Introduce Bias for Reducing Mortality in the Antiplatelet Therapy Group?. Journal of the American College of Cardiology, 78(20), e173-e174. https://doi.org/10.1016/j.jacc.2021.09.012
Kawashima, Hideyuki, et al. "Reply: Does Repeat Revascularization Introduce Bias for Reducing Mortality in the Antiplatelet Therapy Group?." Journal of the American College of Cardiology vol. 78,20 (2021): e173-e174. doi: https://doi.org/10.1016/j.jacc.2021.09.012
Kawashima H, Serruys PW, Wang R, Lunardi M, Onuma Y. Reply: Does Repeat Revascularization Introduce Bias for Reducing Mortality in the Antiplatelet Therapy Group?. J Am Coll Cardiol. 2021 Nov 16;78(20):e173-e174. doi: 10.1016/j.jacc.2021.09.012. PMID: 34763784.
Copy Download .nbib Format: NLM
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.

Lancet (London, England)

Xu B, Tu S, Song L, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Fu X, Liu J, Zhao Y, Escaned J, Wang Y, Fearon WF, Dou K, Kirtane AJ, Wu Y, Serruys PW, Yang W, Wijns W, Guan C, Leon MB, Qiao S, Stone GW.
PMID: 34742368
Lancet. 2021 Dec 11;398(10317):2149-2159. doi: 10.1016/S0140-6736(21)02248-0. Epub 2021 Nov 04.

BACKGROUND: Compared with visual angiographic assessment, pressure wire-based physiological measurement more accurately identifies flow-limiting lesions in patients with coronary artery disease. Nonetheless, angiography remains the most widely used method to guide percutaneous coronary intervention (PCI). In FAVOR III China,...

Cite
Xu B, Tu S, Song L, et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet. 2021;398(10317):2149-2159doi: 10.1016/S0140-6736(21)02248-0.
Xu, B., Tu, S., Song, L., Jin, Z., Yu, B., Fu, G., Zhou, Y., Wang, J., Chen, Y., Pu, J., Chen, L., Qu, X., Yang, J., Liu, X., Guo, L., Shen, C., Zhang, Y., Zhang, Q., Pan, H., Fu, X., Liu, J., Zhao, Y., Escaned, J., Wang, Y., Fearon, W. F., Dou, K., Kirtane, A. J., Wu, Y., Serruys, P. W., Yang, W., Wijns, W., Guan, C., Leon, M. B., Qiao, S., Stone, G. W. (2021). Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet (London, England), 398(10317), 2149-2159. https://doi.org/10.1016/S0140-6736(21)02248-0
Xu, Bo, et al. "Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial." Lancet (London, England) vol. 398,10317 (2021): 2149-2159. doi: https://doi.org/10.1016/S0140-6736(21)02248-0
Xu B, Tu S, Song L, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Fu X, Liu J, Zhao Y, Escaned J, Wang Y, Fearon WF, Dou K, Kirtane AJ, Wu Y, Serruys PW, Yang W, Wijns W, Guan C, Leon MB, Qiao S, Stone GW. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet. 2021 Dec 11;398(10317):2149-2159. doi: 10.1016/S0140-6736(21)02248-0. Epub 2021 Nov 04. PMID: 34742368.
Copy Download .nbib Format: NLM
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.

JACC. Cardiovascular interventions

Kawashima H, Serruys PW, Hara H, Ono M, Gao C, Wang R, Garg S, Sharif F, de Winter RJ, Mack MJ, Holmes DR, Morice MC, Kappetein AP, Thuijs DJFM, Milojevic M, Noack T, Mohr FW, Davierwala PM, Onuma Y.
PMID: 34973904
JACC Cardiovasc Interv. 2021 Dec 20; doi: 10.1016/j.jcin.2021.10.026. Epub 2021 Dec 20.

OBJECTIVES: The aim of this study was to assess 10-year all-cause mortality in patients with heavily calcified lesions (HCLs) undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).BACKGROUND: Limited data are available on very long term outcomes...

Cite
Kawashima H, Serruys PW, Hara H, et al. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. JACC Cardiovasc Interv. 2021;doi: 10.1016/j.jcin.2021.10.026.
Kawashima, H., Serruys, P. W., Hara, H., Ono, M., Gao, C., Wang, R., Garg, S., Sharif, F., de Winter, R. J., Mack, M. J., Holmes, D. R., Morice, M. C., Kappetein, A. P., Thuijs, D. J. F. M., Milojevic, M., Noack, T., Mohr, F. W., Davierwala, P. M., Onuma, Y. (2021). 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. JACC. Cardiovascular interventions, . https://doi.org/10.1016/j.jcin.2021.10.026
Kawashima, Hideyuki, et al. "10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification." JACC. Cardiovascular interventions vol. (2021). doi: https://doi.org/10.1016/j.jcin.2021.10.026
Kawashima H, Serruys PW, Hara H, Ono M, Gao C, Wang R, Garg S, Sharif F, de Winter RJ, Mack MJ, Holmes DR, Morice MC, Kappetein AP, Thuijs DJFM, Milojevic M, Noack T, Mohr FW, Davierwala PM, Onuma Y. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. JACC Cardiovasc Interv. 2021 Dec 20; doi: 10.1016/j.jcin.2021.10.026. Epub 2021 Dec 20. PMID: 34973904.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 270 entries